MedTrace Logo

ALGRX 4975 in the Treatment of Tennis Elbow

NCT00130949 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2006-12-20

No results posted yet for this study

Summary

Tennis elbow is a painful condition that results from repetitive arm movement with overuse of muscles, e.g. when playing tennis. A single injection of ALGRX 4975 has the potential to reduce pain for a period of weeks to months. This study will test the efficacy and safety of ALGRX 4975 in the treatment of patients with tennis elbow.

Conditions

  • Tennis Elbow

Interventions

DRUG

ALGRX 4975

Sponsors & Collaborators

  • AlgoRx Pharmaceuticals

    lead INDUSTRY

Principal Investigators

  • Gabriel Vasko, MD PhD · Ortopedicko-Traumatologicka Klinika, Kosice, Slovak Republic

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-11-30
Completion
2005-11-30

Countries

  • Slovakia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00130949 on ClinicalTrials.gov